Qiagen
QGEN
277 hedge funds and large institutions have $6.22B invested in Qiagen in 2023 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 104 increasing their positions, 90 reducing their positions, and 46 closing their positions.
136% more call options, than puts
Call options by funds: $12.5M | Put options by funds: $5.31M
16% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 90
15% more capital invested
Capital invested by funds: $5.4B → $6.22B (+$819M)
3.76% more ownership
Funds ownership: 55.28% → 59.04% (+3.8%)
2% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 46
0% more funds holding
Funds holding: 277 → 277 (0)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$122M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$72.6M |
| 3 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$53.8M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$49.4M |
| 5 |
Goldman Sachs
New York
|
+$48.9M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$116M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$58.2M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$28.3M |
| 4 |
NC
Nekton Capital
London,
United Kingdom
|
-$24.9M |
| 5 |
VCP
Varenne Capital Partners
Paris,
France
|
-$24.6M |
QGEN Hedge Fund Activity: Q4 2023 in Review
277 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Qiagen (QGEN) for Q4 2023, worth a combined $6.22B — up 15% from $5.4B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new QGEN positions and 46 closed out — a net gain of 1 holder — while 104 added to existing stakes and 90 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $122M. The largest seller was Point72 Asset Management, cutting an estimated $116M.
- 277 institutional investors held Qiagen (QGEN) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $6.22B of Qiagen stock for Q4 2023, up 15% quarter-over-quarter.
- 47 funds opened new Qiagen positions in Q4 2023 and 46 closed out, a net change of +1 holder.
- The largest Qiagen buyer in Q4 2023 was Morgan Stanley, an estimated $122M added.
- The largest Qiagen seller in Q4 2023 was Point72 Asset Management, an estimated $116M sold.
Based on aggregated 13F filings for Q4 2023.